Get the Stockscreener App
4.7323
5.68%
-0.2877
Annexon Inc stock is traded at $4.7323, with a volume of 1.59M.
It is down -5.68% in the last 24 hours and up +16.63% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$5.02
Open:
$5.1
24h Volume:
1.59M
Relative Volume:
0.63
Market Cap:
$702.05M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-2.6736
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
-7.34%
1M Performance:
+16.63%
6M Performance:
+68.51%
1Y Performance:
-13.91%
1-Day Range:
$4.65
$5.16
1-Week Range:
$4.65
$5.18
52-Week Range:
$1.285
$5.66
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650) 822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
4.71 | 748.26M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.79 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
774.65 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.40 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
840.72 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.51 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-23-25 | Initiated | Chardan Capital Markets | Buy |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-23 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-30-23 | Initiated | Wells Fargo | Overweight |
| May-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| May-25-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
Annexon (NASDAQ:ANNX) Stock Price Down 6.9%Should You Sell? - MarketBeat
What analysts say about Annexon Inc stockMorning Star Patterns & Small Capital Investment Tips - earlytimes.in
Breakout Zone: Will Annexon Inc stock maintain growth story2025 Price Momentum & Growth Oriented Trading Recommendations - moha.gov.vn
Aug Macro: Will WAVE stock continue upward momentumExit Point & Risk Controlled Swing Trade Alerts - moha.gov.vn
Annexon (NASDAQ:ANNX) Upgraded at Chardan Capital - MarketBeat
Clear Street asserts buy rating on Annexon, Inc. (ANNX) amid progress on pipeline development - MSN
Chardan Capital Initiates Coverage on ANNX with a Buy Rating | A - GuruFocus
Chardan Initiates Annexon at Buy With $16 Price Target - marketscreener.com
Chardan Capital Markets initiates Annexon Biosciences stock with Buy rating By Investing.com - Investing.com South Africa
Chardan Capital Markets initiates Annexon Biosciences stock with Buy rating - Investing.com
Annexon (ANNX) price target increased by 27.19% to 14.79 - MSN
Annexon, Inc.(NasdaqGS: ANNX) added to S&P Biotechnology Select Industry Index - marketscreener.com
Annexon Inc.: New Coverage Initiates Buy Rating – Stock on the Rise - StocksToTrade
Is Annexon Inc. stock oversold or undervaluedJuly 2025 PreEarnings & Risk Managed Investment Strategies - Улправда
Why Annexon Inc. stock is recommended by analystsJuly 2025 Patterns & Growth Oriented Trade Recommendations - Улправда
How resilient is Annexon Inc. stock in market downturnsOptions Play & Momentum Based Trading Signals - Улправда
Annexon Inc. Sees Promising Growth Following Insider Activity and Positive Clinical Results - StocksToTrade
Clear Street Boosts Annexon with Buy Rating Tied to Promising Study Results - timothysykes.com
Will Annexon Inc. stock benefit from AI adoptionM&A Rumor & Risk Adjusted Buy and Sell Alerts - Улправда
Is Annexon Inc. stock safe for conservative investorsJuly 2025 Closing Moves & High Accuracy Buy Signal Tips - Улправда
Annexon (NASDAQ:ANNX) Shares Up 9.6%Here's Why - MarketBeat
Is Annexon Inc. stock a buy on dipsInsider Buying & Community Verified Trade Signals - DonanımHaber
Quarterly Earnings: Is Annexon Inc. stock safe for conservative investors2025 Technical Patterns & Verified Swing Trading Watchlist - Улправда
Will Annexon Inc. stock maintain growth story2025 Earnings Impact & AI Based Buy/Sell Signal Reports - Bölüm Sonu Canavarı
Clear Street Asserts Buy Rating on Annexon, Inc. (ANNX) amid Progress on Pipeline Development - Insider Monkey
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Hold" by Analysts - MarketBeat
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biotech firm Annexon gives new hire 19,000 stock options in long-term deal - Stock Titan
3 High Growth Tech Stocks To Watch In The US Market - simplywall.st
With Annexon Up 14%, Insider Buyers Count Their Returns - Yahoo Finance
Sirios Capital Management L P Has $2.38 Million Stake in Annexon, Inc. $ANNX - MarketBeat
Annexon (NASDAQ:ANNX) Shares Up 6.2%Time to Buy? - MarketBeat
Independent Director of Annexon Jung Choi Buys More Stock - simplywall.st
Insider Buying: Annexon (NASDAQ:ANNX) Director Buys 4,115 Shares of Stock - MarketBeat
Annexon (NASDAQ:ANNX) Director Acquires $138,270.00 in Stock - MarketBeat
Insider Buying: William Carson Acquires Additional Shares of Ann - GuruFocus
Annexon (NASDAQ:ANNX) Stock Price Up 6.7%What's Next? - MarketBeat
Annexon, Inc. $ANNX Position Raised by Sio Capital Management LLC - MarketBeat
Clear Street Initiates Coverage on Annexon (ANNX) with a 'Buy' R - GuruFocus
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Annexon Inc Stock (ANNX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Carson William H. | Director |
Dec 01 '25 |
Buy |
4.47 |
4,115 |
18,394 |
50,290 |
| Satter Muneer A | Director |
Nov 21 '25 |
Buy |
4.28 |
422,613 |
1,808,784 |
9,728,637 |
| Satter Muneer A | Director |
Nov 20 '25 |
Buy |
4.48 |
400,000 |
1,792,000 |
9,306,024 |
| Satter Muneer A | Director |
Nov 19 '25 |
Buy |
3.94 |
500,000 |
1,970,000 |
8,906,024 |
| Satter Muneer A | Director |
Nov 18 '25 |
Buy |
3.18 |
500,000 |
1,590,000 |
8,406,024 |
| Satter Muneer A | Director |
Nov 17 '25 |
Buy |
2.99 |
500,000 |
1,495,000 |
7,906,024 |
| Carson William H. | Director |
Oct 30 '25 |
Buy |
3.17 |
4,115 |
13,045 |
46,175 |
| Carson William H. | Director |
Sep 30 '25 |
Buy |
3.05 |
4,115 |
12,551 |
42,060 |
| Carson William H. | Director |
Sep 02 '25 |
Buy |
2.09 |
4,115 |
8,600 |
37,945 |
| Carson William H. | Director |
Jul 30 '25 |
Buy |
2.43 |
4,115 |
9,999 |
33,830 |
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):